ZENYF - ZEN develops graphene-based compound against bacterial/viral infections

ZEN Graphene Solutions ([[ZENYF]] +15.4%) has developed a potential graphene-based antibiotic, antiviral and antifungal compound. Based on testing results, the compound is 99.9% effective against both gram-positive and gram-negative aerobic bacteria, as well as against Candida Albicans (fungus/yeast)Extremely low Minimum Inhibitory Concentrations leading to the potential use in humansAdditional testing required to determine full spectrum of activity against other pathogens and cytotoxicity studies are currently underway.Potential use to treat infection of upper and lower respiratory tract.

For further details see:

ZEN develops graphene-based compound against bacterial/viral infections